ATE491034T1 - Verfahren und zusammensetzungen für stabile transgene pharmazeutika und ihre verwendung als kontrazeptiva - Google Patents

Verfahren und zusammensetzungen für stabile transgene pharmazeutika und ihre verwendung als kontrazeptiva

Info

Publication number
ATE491034T1
ATE491034T1 AT02725654T AT02725654T ATE491034T1 AT E491034 T1 ATE491034 T1 AT E491034T1 AT 02725654 T AT02725654 T AT 02725654T AT 02725654 T AT02725654 T AT 02725654T AT E491034 T1 ATE491034 T1 AT E491034T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
methods
animal
contraceptives
pharmaceutics
Prior art date
Application number
AT02725654T
Other languages
English (en)
Inventor
Dwayne Kirk
Hugh Mason
Amanda Walmsley
Charles Arntzen
Original Assignee
Thompson Boyce Plant Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thompson Boyce Plant Res filed Critical Thompson Boyce Plant Res
Application granted granted Critical
Publication of ATE491034T1 publication Critical patent/ATE491034T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT02725654T 2001-04-13 2002-04-12 Verfahren und zusammensetzungen für stabile transgene pharmazeutika und ihre verwendung als kontrazeptiva ATE491034T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28388401P 2001-04-13 2001-04-13
PCT/US2002/011693 WO2002083072A2 (en) 2001-04-13 2002-04-12 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives

Publications (1)

Publication Number Publication Date
ATE491034T1 true ATE491034T1 (de) 2010-12-15

Family

ID=23087984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02725654T ATE491034T1 (de) 2001-04-13 2002-04-12 Verfahren und zusammensetzungen für stabile transgene pharmazeutika und ihre verwendung als kontrazeptiva

Country Status (12)

Country Link
EP (1) EP1389997B1 (de)
JP (1) JP4500493B2 (de)
KR (1) KR20030096319A (de)
CN (1) CN1311077C (de)
AT (1) ATE491034T1 (de)
AU (1) AU2002256205B2 (de)
BR (1) BR0208880A (de)
CA (1) CA2441699A1 (de)
DE (1) DE60238528D1 (de)
ES (1) ES2357321T3 (de)
MX (1) MXPA03009196A (de)
WO (1) WO2002083072A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009188A1 (en) * 2002-09-19 2005-01-13 Kitto G. Barrie Animal immunocontraceptives expressed in plants and uses thereof
EP1546309A4 (de) * 2002-09-19 2007-05-23 Res Dev Foundation In pflanzen exprimierte tierische immunkontrazeptiva
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
AU2004222243A1 (en) * 2003-03-18 2004-09-30 Rutgers, The State University Improved plant transformation
AU2004235813B2 (en) * 2003-05-05 2010-07-29 Boyce Thompson Institute For Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
CN1981835B (zh) * 2005-12-15 2010-12-15 孔庆建 一种中药避孕液及其制备工艺
DE102016204033A1 (de) * 2016-03-11 2017-09-14 Universität Rostock Maßnahmen und Methoden zur Schadtierbekämpfung
CN107158373B (zh) * 2017-05-25 2021-06-11 新疆大学 阿魏菇多糖在制备犬透明带3dna疫苗佐剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650689T2 (de) * 1985-04-18 1999-04-08 Biotechnology Australia Pty. Ltd., East Roseville, Neussuedwales Rekombinantes inhibin
IL91525A0 (en) * 1988-09-06 1990-04-29 Univ Washington Transgenic plants,pharmaceutical compositions containing the same and methods for the preparation thereof
US5484719A (en) * 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
ATE241374T1 (de) * 1996-01-31 2003-06-15 Aboca S P A Verfahren zur gewinnung von multifraktions- trockenextrakten aus pflanzen
FR2760366B1 (fr) * 1997-03-04 2000-08-11 Harbex Limited Hydrolysat d'extrait lyophilise de potiron et son procede de fabrication
JP2002517999A (ja) * 1998-06-17 2002-06-25 ベス イスラエル ディーコネス メディカル センター 抗血管形成タンパク質およびその使用方法
RU2001111881A (ru) * 1998-10-07 2003-06-20 Зингента Партисипейшнс Аг (Ch) Терапевтически активные протеины в растениях

Also Published As

Publication number Publication date
CA2441699A1 (en) 2002-10-24
CN1639331A (zh) 2005-07-13
EP1389997B1 (de) 2010-12-08
BR0208880A (pt) 2004-12-07
WO2002083072A2 (en) 2002-10-24
JP4500493B2 (ja) 2010-07-14
DE60238528D1 (de) 2011-01-20
CN1311077C (zh) 2007-04-18
AU2002256205B2 (en) 2007-08-16
EP1389997A2 (de) 2004-02-25
KR20030096319A (ko) 2003-12-24
MXPA03009196A (es) 2004-02-17
ES2357321T3 (es) 2011-04-25
JP2004537287A (ja) 2004-12-16
EP1389997A4 (de) 2004-08-11
WO2002083072A3 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
DE60120691D1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
BR0008188A (pt) Inibidores de fator de diferenciação de crescimento e usos para os mesmos
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
NO20016159D0 (no) Serinproteinaser fra fisk og deres farmasöytiske og kosmetiske anvendelse
ATE443758T1 (de) Zusammensetzungen und verfahren zur isolierung, vermehrung und differenzierung nicht-embryonale menschlicher stammzellen und deren verwendungen
EA200700382A1 (ru) Фунгицидные композиции
ATE337777T1 (de) Zusammensetzung zur behandlung von huf- und klauenerkrankungen
AR061930A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos
DE60212627D1 (de) Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
ATE345839T1 (de) Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
DE60238528D1 (de) Ene pharmazeutika und ihre verwendung als kontrazeptiva
ATE343415T1 (de) Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
DE60124526D1 (de) Methode zur identifizierung von helicobacter antigenen
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE60108094D1 (de) Die verwendung von retinoid antagonisten oder agonisten für die behandlung von gelenk-und knochenpathologien
DE60005952D1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
HN1998000141A (es) Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientom para fabricarla.
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür
NO20005345L (no) Fruktbarhetsforbedrende preparat og anvendelse derav
UA36895A (uk) Спосіб трансплантації рогівки у тварин
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen
PL440339A1 (pl) Frakcja białkowa otrzymana z płynu celomatycznego dżdżownicy Dendrobaena veneta do zastosowania w leczeniu raka szyjki macicy ludzkiej
NO20070661L (no) Anvendelsen av medisinske planter og ekstrakter derav for dyrs velvaere i veterinaer medisin og zooteknikk

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties